Can you recall the initial cancer for keytruda's launch?

What cancer was the first Keytruda (pembrolizumab) approved for?

Keytruda’s first FDA launch approval in the U.S. was for unresectable or metastatic melanoma.

Why that first approval matters

The original approval focused on melanoma before later expansions to many other cancers (for example, lung, head and neck, bladder, and others).

Sources

• [1] DrugPatentWatch.com – Keytruda (pembrolizumab): https://www.drugpatentwatch.com/